IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2003;44:2634-2643.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.02-1135

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schreiber, W.
Right arrow Articles by Behrens-Baumann, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schreiber, W.
Right arrow Articles by Behrens-Baumann, W.

Combined Topical Fluconazole and Corticosteroid Treatment for Experimental Candida albicans Keratomycosis

Wolfram Schreiber,1 Antje Olbrisch,1 Christian K. Vorwerk,1 Wolfgang König,2 and Wolfgang Behrens-Baumann1

1From the Department of Ophthalmology and the 2Institute of Microbiology, Faculty of Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

PURPOSE. To determine the most efficient time point and concentration of topical corticosteroids in Candida albicans keratitis treated with fluconazole.

METHODS. Corneas of 105 rabbits were infected with viable yeast cells of C. albicans (2.5 x 105). After a 48-hour incubation period, seven groups of animals were treated for 21 days with fluconazole, with group I acting as a control, and groups II to VII receiving adjunct therapy with the corticosteroid prednisolone (5 or 10 times daily; 3, 9, or 15 days after infection). The degree of corneal infiltration, ulceration, corneal clouding, hypopyon, conjunctivitis, neovascularization, and corneal perforation was monitored over a 24-day period, as well as recultivation and resistance to fluconazole of the C. albicans pathogen.

RESULTS. The control group showed the highest level of corneal clouding and neovascularization. In comparison, by day 24, the majority of groups also treated with prednisolone displayed significantly less corneal clouding and neovascularization. An immediate decrease in corneal clouding was observed in groups treated with additional low- or high-dose prednisolone from day 9 after inoculation. After additional prednisolone treatment from day 9 or 15 after inoculation, no significant difference was detected in the recultivation rate of C. albicans compared with the control. Early administration of prednisolone (day 3, low and high dose) resulted in the recultivation of significantly more C. albicans.

CONCLUSIONS. Fluconazole plus adjunct high-dose prednisolone treatment was most effective when administered 9 days after infection. The delayed application of corticosteroids after treatment with antimycotic drugs in cases of fungal keratitis is therefore not contraindicated and may be beneficial in patients.





This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
V Peponis, J B Herz, and H E Kaufman
The role of corticosteroids in fungal keratitis: a different view
Br. J. Ophthalmol., September 1, 2004; 88(9): 1227 - 1227.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology